Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004324334 | SCV003984859 | uncertain significance | not specified | 2023-05-30 | criteria provided, single submitter | clinical testing | The c.992G>A (p.G331E) alteration is located in exon 7 (coding exon 7) of the AXL gene. This alteration results from a G to A substitution at nucleotide position 992, causing the glycine (G) at amino acid position 331 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |